Promising-Compound-Could-Offer-New-Treatment-for-Heart-Failure
Promising Compound Could Offer New Treatment for Heart Failure
The discovery of a new molecular pathway responsible for causing heart failure lays the foundation for an entirely new way of treating a diseased heart by targeting cell nucleus....
Tags: heart failure, new molecular pathway, JQ1...
August 3, 2013
New-Orphan-Drug-for-the-Treatment-of-Trigeminal-Neuralgia
New Orphan-Drug for the Treatment of Trigeminal Neuralgia
Convergence’s novel sodium channel blocker has been granted orphan-drug designation by the FDA....
Tags: Trigeminal neuralgia, Convergence, sodium channel blocker...
August 3, 2013
New-Psoriasis-Drug-Better-Than-Enbrel
New Psoriasis Drug Better Than Enbrel
Secukinumab, a new drug from Novartis, was found to be better than Enbrel at curing psoriasis. ...
Tags: Secukinumab, Novartis, Enbrel, psoriasis, Amgen...
July 20, 2013
Drug-candidate-leads-to-increased-endurance
Drug candidate leads to increased endurance
A drug candidate developed by the Scripps Research Institute has been shown to increase exercise endurance in animals. This has great implications for those with conditions that may decrease a person's tolerance for exercise....
Tags: Scripps Research Institute, drug candidate, increase endurance...
July 15, 2013
Entry-of-new-Type-2-Diabestes-drug-in-the-UK-Only-one-per-day
Entry of new Type 2 Diabestes drug in the UK: Only one per day
The new drug, Lixisenatide, with the brand name Lyxumia is cheaper than existing drugs and it can be self administered daily once with an injection pen. It will work on GLP-1 hormone and control insulin level....
Tags: Type 2 Diabetes, Lyxumia, Lixisenatide ...
July 15, 2013
Novartis-Serelaxin-is-a-breakthrough-in-heart-drug-development
Novartis' Serelaxin is a breakthrough in heart drug development
Novartis have given breakthrough therapy status by FDA to an investigational treatment for patients with acute heart failure....
Tags: heart failure, drug, Serelaxin...
July 15, 2013
Could-there-be-Hope-for-Children-with-Progeria
Could there be Hope for Children with Progeria?
A phase II drug trial of lonafarnib suggested that it might be possible to ease some of the effects of this rare disease, which results in death at an average age of 13...
Tags: Progeria, lonafarnib, farnesyltransferase inhibitor ...
August 3, 2013
Fabricated-Data-in-Novartis-Drug-Trial
Fabricated Data in Novartis Drug Trial
Japanese minister confirms that data from a large Japanese study was fabricated....
Tags: Novartis, Diovan, drug trial...
July 22, 2013
3-New-COPD-Drugs
3 New COPD Drugs
In the US, COPD is the third leading cause of death. Three new drugs in the works give hope to COPD patients....
Tags: COPD, Anoro, Spiriva...
July 20, 2013
No-more-chemo-Docs-say-its-not-so-far-fetched
No more chemo: Docs say it's not so far-fetched
There's a revolution occurring in cancer treatment, and it could mean the end of chemotherapy. When it comes to taming tumors, the strategy has always been fairly straightforward. Remove the offending and abnormal growth by any means, in the most effective way possib...
Tags: Cancer, targeted therapies, targeted drugs...
July 15, 2013
FDA-asks-for-input-on-antibiotic-drug-discovery
FDA asks for input on antibiotic drug discovery
A US Food and Drug Administration (FDA) taskforce working on advancing antibiotic drug development has outlined its initial areas of interest, and proposed a list of pathogens that could trigger extended exclusivity periods for drug candidates....
Tags: antibiotic drug development, FDA, drug candidate...
July 15, 2013
MOST VIEWED
First «« Prev 7 8 9 10 11 Next »»  Last

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013